Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Instil Bio, Inc. (TIL)
|
Add to portfolio |
|
|
|
| Price: |
$17.30
| | Metrics |
| OS: |
130.1
|
M
| |
|
|
| Market cap: |
$2.25
|
B
| |
-32
|
% ROIC
|
|
Net cash:
|
$120
|
M
| |
$0.92
|
per share
|
|
EV:
|
$2.13
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($120)
|
M
| |
|
|
| EPS |
($1.02)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 141.1 | 0.0 | 0.1 | 4.0 |
| Revenue growth | | -100.0% | -96.6% | |
| Cost of goods sold | 282.1 | 0.0 | -34.4 | 8.1 |
| Gross profit | -141.1 | 0.0 | 34.5 | -4.0 |
| Gross margin | -100.0% | | 25014.5% | -100.0% |
| Research and development | | 107.3 | 19.4 | |
| General and administrative | 62.2 | 48.3 | 14.4 | 2.6 |
| EBIT | -203.3 | -155.6 | -33.0 | -6.6 |
| EBIT margin | -144.1% | | -23944.9% | -163.5% |
| Pre-tax income | -225.3 | -156.8 | -37.6 | -6.5 |
| Income taxes | 0.0 | 0.0 | 0.2 | 0.0 |
| Tax rate | 0.0% | | | 0.0% |
| Net income | 0.0 | -156.8 | -37.7 | -6.5 |
| Net margin | 0.0% | | -27346.4% | -162.0% |
| |
| Diluted EPS | $0.00 | ($1.48) | ($2.36) | ($0.55) |
| Shares outstanding (diluted) | 129.5 | 106.0 | 16.0 | 11.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|